Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

Shares of Candel Therapeutics Inc. surged nearly 10% on Wednesday and extended gains in after-hours trading following a bullish call from Wall Street. Canaccord initiated coverage on the stock with a ...

The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.

As previously reported, Canaccord initiated coverage of Candel Therapeutics (CADL) with a Buy rating and $20 price target The firm expects ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and clinical advancements, ...

The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

The results were impressive. PAC-MANN correctly identified pancreatic cancer in 98% of cases and was able to detect ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...